Clinical Trial Update: A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase II study evaluated the safety and efficacy of PDC-1421 capsules in patients with Major Depressive Disorder; the trial is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PDC-1421

Snippet

Sponsor: BioLite, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-09-29